University of Limerick’s Pharmaceutical Manufacturing Technology Centre to expand operations with €5m funding injection
September 3, 2019Manufacturing and Production Ireland, UK, pharma
The Pharmaceutical Manufacturing Technology Centre (PMTC) at the University of Limerick’s Bernal Institute in Ireland has secured €5 million ($5.5 …
Mylan gets provisional FDA greenlight for generic version of Lilly’s blockbuster cancer drug Alimta
September 2, 2019Sales and Marketing Alimta, Cancer, Eli Lilly, FDA, Mylan, pharma
Mylan has scored a preliminary approval in the US from the FDA for its generic version of Eli Lilly’s blockbuster …
No-deal Brexit will “make the disintegration of the health service an ever more real prospect”, BMA warns
September 2, 2019Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMA, NHS, UK, brexit, pharma
As the UK hurtles towards a catastrophic and autocratic exit from the European Union, the British Medical Association (BMA) has …
AstraZeneca presents strong Phase 3 Brilinta data for reducing CV risk
September 2, 2019Research and Development, Sales and Marketing AstraZeneca, Brilinta, pharma
AstraZeneca has unveiled new positive Phase 3 data on the efficacy of Brilinta (ticagrelor) in combination with aspirin, showing that …
Novartis’ Entresto narrowly misses Phase 3 goal in heart failure patients
September 2, 2019Research and Development, Sales and Marketing Entresto, Novartis, heart failure, pharma
New Phase 3 data for Novartis’ Entresto (sacubitril/valsartan) have been released, showing that the therapy narrowly missed its primary endpoint …
Roche’s Xofluza reduces risk of catching flu by 86% in Phase 3 trial
September 2, 2019Research and Development, Sales and Marketing Roche, Xofluza, flu, influenza, pharma
Roche has brought forward new Phase 3 data on Xofluza (baloxavir marboxil), proving the therapy’s efficacy in the preventative treatment …
Top Ten most popular articles on Pharmafile.com this week
August 30, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top 10
Happy Friday! It’s time for another rundown of the top 10 most popular articles with Pharmafile.com readers this week.10. NICE …
Roche’s Tecentriq combo becomes first EU-approved immunotherapy for triple-negative breast cancer
August 30, 2019Medical Communications, Sales and Marketing EMA, Europe, Roche, breast cancer, pharma, tecentriq
Roche has announced the approval of Tecentriq (atezolizumab), in combination with Celgene’s chemotherapy drug Abraxane (nab paclitaxel), by the European …
Genmab & Novartis’ ofatumumab tops Sanofi’s Aubagio in relapsing multiple sclerosis
August 30, 2019Medical Communications, Research and Development Genmab, Novartis, multiple sclerosis, ofatumumab, pharma
Genmab and Novartis have revealed positive new data from two Phase 3 studies of its monthly subcutaneous formulation of ofatumumab …
AbbVie shuts down Rova-T development in first-line advanced small-cell lung cancer following another trial failure
August 30, 2019Medical Communications, Research and Development AbbVie, pharma, rova-t, small-cell lung cancer
AbbVie has announced its intention to terminate development of Rova-T (rovalpituzumab tesirine) in the first-line maintenance of advanced small-cell lung …
Using advanced digital capabilities to unlock hard-to-see HCPs access
August 29, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing digital pharma, pharma, veeva
Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their channel preferences and ensure they are getting …
Celgene signs $1.5bn partnership with Immatics to fight cancer with engineered T-cell therapies
August 29, 2019Research and Development Cancer, Celgene, immatics, immunotherapy, pharma
Celgene and biopharma firm Immatics Biotechnologies have announced that they have entered a partnership valued at a potential $1.5 billion …
FDA warns three Hepatitis C drugs may worsen liver function in some rare cases
August 29, 2019Medical Communications, Research and Development AbbVie, FDA, Gilead, HCV, MSD, hepatitis C, public health
The FDA has warned that three Hepatitis C (HCV) drugs made by AbbVie, Gilead and MSD are worsening liver function …
AstraZeneca lupus drug makes comeback to meet main goal at Phase 3
August 29, 2019Research and Development AstraZeneca, Lupus, anifrolumab, pharma
AstraZeneca has lifted the curtain on new Phase 3 data for anifrolumab, noting that the drug met its primary endpoint …
Oral contraceptive use as teenager linked to depression as an adult, study says
August 29, 2019Research and Development MDD, depression, hormones, oral contraceptives, psychiatry, psychology
Women who have used oral contraceptives as teenagers are more likely to experience depression later in life, according to a …
Alexion’s Soliris scoops up expanded EU approval in neuromyelitis optica spectrum disorder
August 28, 2019Research and Development, Sales and Marketing Alexion, FDA, US, pharma, soliris
Alexion has announced the expanded EU approval of Soliris (eculizumab) as a treatment for neuromyelitis optica spectrum disorder (NMOSD) in …
Sea snail chemical could be used as preventative treatment for bowel cancer, study shows
August 28, 2019Research and Development Australia, Cancer, bowel cancer, pharma, research
A chemical produced by Australian sea snails is showing promise as a potential treatment for cancer, according to researchers from …
Johns Hopkins researchers to study psilocybin as a treatment for anorexia in Phase 1 trial
August 28, 2019Research and Development Johns Hopkins, Magic mushrooms, anorexia, mushrooms, pharma, psilocybin
Scientists at Johns Hopkins University are exploring psilocybin as a potential treatment for chronic anorexia nervosa. Researchers at Johns Hopkins …
Over half of all US/EU regulator warnings issued to Indian and Chinese manufacturers, report finds
August 28, 2019Manufacturing and Production, Research and Development China, India, MHRA, UK, manufacturing, pharma
Concerns have been raised concerning the integrity of the global supply chain after a report from The Pharmaceutical Journal revealed …
Sacklers could give up Purdue Pharma and settle 2,000 lawsuits for $10-12 billion, proposal says
August 28, 2019Research and Development OxyContin, Purdue Pharma, Sackler family, opioid crisis, opioids, pharma
The Sackler family are offering to settle more than 2,000 opioid crisis lawsuits for between $10-12 billion, according to NBC. …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
